Denali Therapeutics Growth Metrics (2017-2026) | DNLI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	0.06M	-0.10M	-0.02M	0.07M	0.03M	-0.16M	-0.09M	-0.02M	0.02M	-0.58M
EBITDA Margin Growth (3y) (Quarter)	0.31M	0.16M	-0.02M	0.09M	0.14M	-0.20M	0.02M	11.50M	0.11M	-0.83M
EBITDA Margin Growth (5y) (Quarter)								0.37M	0.35M	-0.58M
EBITDA Margin (QoQ) (Quarter)	0.05M	-0.12M	0.15M	71.00	0.00M	-0.31M	0.21M	0.07M	0.04M	-0.90M
EBIT Margin Growth (1y) (Quarter)	0.06M	-0.10M	-0.02M	0.07M	0.03M	-0.16M	-0.09M	-0.02M	0.02M	-0.58M
EBIT Margin Growth (3y) (Quarter)	0.31M	0.16M	-0.02M	0.09M	0.14M	-0.20M	0.02M	11.50M	0.11M	-0.83M
EBIT Margin Growth (5y) (Quarter)								0.37M	0.35M	-0.58M
EBIT Margin (QoQ) (Quarter)	0.05M	-0.12M	0.15M	71.00	0.00M	-0.31M	0.21M	0.07M	0.04M	-0.90M
EBT Margin Growth (1y) (Quarter)	0.06M	-0.10M	-0.02M	0.07M	0.03M	-0.15M	-0.08M	-0.02M	0.02M	-0.48M
EBT Margin Growth (3y) (Quarter)	0.29M	0.14M	-0.02M	0.08M	0.13M	-0.20M	0.27M	10.91M	0.11M	-0.72M
EBT Margin Growth (5y) (Quarter)								1.86M	0.34M	-0.49M
EBT Margin (QoQ) (Quarter)	0.05M	-0.12M	0.14M	-814.00	0.01M	-0.29M	0.21M	0.07M	0.04M	-0.79M
Enterprise Value Growth (1y) (Quarter)	-138.17%	-8.11%	41.12%	32.24%	18.36%	-6.44%	-54.40%	-34.56%	-11.45%	-0.29%	22.58%	27.29%	24.76%	24.58%	19.54%	12.70%	-0.32%	-1.39%	-4.27%	-20.75%
Enterprise Value Growth (3y) (Quarter)	-52.02%	-40.47%	-23.07%	-25.41%	-30.70%	-32.14%	-47.62%	-29.94%	-29.41%	-4.89%	11.05%	12.80%	11.87%	6.97%	1.29%	5.12%	5.60%	8.47%	13.40%	8.48%
Enterprise Value Growth (5y) (Quarter)				-91.94%	-91.67%	-98.08%	-26.89%	-28.11%	-26.16%	-24.23%	-17.38%	-14.05%	-13.36%	-11.78%	-14.91%	-6.85%	-10.34%	2.47%	10.00%	6.91%
Enterprise Value (QoQ) (Quarter)	7.37%	20.61%	16.72%	-10.64%	-11.61%	-3.50%	-20.81%	3.57%	7.56%	6.86%	6.74%	9.44%	4.36%	6.64%	0.51%	1.73%	-9.91%	5.65%	-2.32%	-13.80%
FCF Margin Growth (1y) (Quarter)	0.04M	-0.08M	-0.03M	0.05M	0.02M	-0.07M	-0.06M	-0.00M	0.01M	-0.47M
FCF Margin Growth (3y) (Quarter)	0.22M	0.23M	-0.02M	0.06M	0.10M	-0.06M		10.63M	0.07M	-0.62M
FCF Margin Growth (5y) (Quarter)								-0.54M	0.25M	-0.31M
FCF Margin (QoQ) (Quarter)	0.03M	-0.04M	0.06M	-0.00M	0.01M	-0.14M	0.08M	0.05M	0.01M	-0.62M
Interest Coverage Ratio Growth (1y) (Quarter)	-1,153.83%	-37.92%	-130.58%	9.55%	4.84%	-13.41%	-19.41%	-58.76%	368.85%	-9.89%	-34.99%	-4.52%	-166.21%	-4.80%	5.18%	-19.11%	93.13%	-8.01%	-2.42%	-383.43%
Interest Coverage Ratio Growth (3y) (Quarter)	-210.60%	-356.42%	-243.54%	25.21%	-243.76%	6.74%	-309.40%	-13.95%	224.20%	-19.79%	-35.59%	-14.49%	-19.20%	-9.31%	-15.19%	-25.49%	50.37%	-7.55%	-9.45%	-81.89%
Interest Coverage Ratio Growth (5y) (Quarter)							-158.53%	-172.42%	139.41%	-159.86%	-129.83%	7.04%	-135.42%	1.36%	-144.75%	-12.99%	-7.84%	-14.24%	-19.91%	-53.93%
Interest Coverage Ratio (QoQ) (Quarter)	14.12%	-35.55%	9.93%	13.74%	9.64%	-61.55%	5.17%	-14.69%	253.01%	-166.03%	-16.50%	11.21%	3.07%	-4.52%	-5.41%	-11.54%	94.41%	-1,543.92%	0.05%	-426.47%
Net Margin Growth (1y) (Quarter)	0.06M	-0.10M	-0.02M	0.07M	0.03M	-0.15M	-0.08M	-0.02M	0.02M	-0.48M
Net Margin Growth (3y) (Quarter)	0.29M	0.14M	-0.02M	0.08M	0.13M	-0.20M	0.27M	10.89M	0.11M	-0.72M
Net Margin Growth (5y) (Quarter)								1.86M	0.34M	-0.49M
Net Margin (QoQ) (Quarter)	0.05M	-0.12M	0.14M	-932.00	0.01M	-0.29M	0.21M	0.07M	0.04M	-0.79M
Operating Margin Growth (1y) (Quarter)	0.06M	-0.10M	-0.02M	0.07M	0.03M	-0.16M	-0.09M	-0.02M	0.02M	-0.58M
Operating Margin Growth (3y) (Quarter)	0.31M	0.16M	-0.02M	0.09M	0.14M	-0.20M	0.02M	11.50M	0.11M	-0.83M
Operating Margin Growth (5y) (Quarter)								0.37M	0.35M	-0.58M
Operating Margin (QoQ) (Quarter)	0.05M	-0.12M	0.15M	71.00	0.00M	-0.31M	0.21M	0.07M	0.04M	-0.90M
Return on Assets Growth (1y) (Quarter)	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)	1.00	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)								0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	-1.00	-1.00
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)	0.01M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-657.00	-935.00	0.00M	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-810.00
Return on Capital Employed Growth (3y) (Quarter)	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-233.00	0.00M	0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-895.00	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M
Return on Capital Employed Growth (5y) (Quarter)								-0.00M	0.00M	0.00M	-947.00	-498.00	-0.00M	-280.00	0.00M	0.00M	723.00	-0.00M	-0.01M	-0.01M
Return on Capital Employed (QoQ) (Quarter)	6.00	-166.00	-0.00M	-30.00	-182.00	-443.00	-2.00	-308.00	0.00M	-146.00	-348.00	254.00	-0.00M	-247.00	-192.00	-471.00	-546.00	-635.00	-176.00	548.00
Return on Invested Capital Growth (1y) (Quarter)									79.00	58.00
Return on Invested Capital (QoQ) (Quarter)						16.00	37.00			-5.00
Return on Sales Growth (1y) (Quarter)	6.00	-10.00	-2.00	7.00	3.00	-15.00	-8.00	-2.00	2.00	-48.00	9.00	3.00	-336.00
Return on Sales Growth (3y) (Quarter)	29.00	14.00	-2.00	8.00	13.00	-20.00	27.00	0.00M	11.00	-72.00	-1.00	8.00	-332.00
Return on Sales Growth (5y) (Quarter)								186.00	34.00	-49.00	-1.00	9.00	-321.00
Return on Sales (QoQ) (Quarter)	5.00	-12.00	14.00	0.00M	1.00	-29.00	21.00	7.00	4.00	-79.00	78.00	0.00M	-335.00

Research Tools

Developers

Denali Therapeutics Growth Metrics (2017-2026) | DNLI

Research Tools

Developers

Denali Therapeutics Growth Metrics (2017-2026) | DNLI

Create an account

Sign In

Reset Password